Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-10T15:51:39.438Z Has data issue: false hasContentIssue false

13 - Parkinson's disease

from Part II - Neurological diseases

Published online by Cambridge University Press:  29 September 2009

Albert Hofman
Affiliation:
Erasmus Universiteit Rotterdam
Richard Mayeux
Affiliation:
Columbia University, New York
Get access

Summary

Parkinson's disease (PD) is one of the most frequent progressive neurodegenerative diseases in the elderly. In spite of extensive research, the etiology of PD is still unknown. Relatively little epidemiologic research has been conducted on PD. In this chapter, recent developments in epidemiologic research of PD will be reviewed. We will successively discuss risk factors, diagnosis, disease frequency, prognosis, intervention, and implications for clinical practice.

Etiology

Numerous studies on risk factors for PD have been published, but the causes of the dopaminergic cell loss have not been settled yet. Most studies were based on register-based prevalent cases which have some well-known methodologic drawbacks as discussed in Chapter 1. In this section, we will mainly focus either on the few prospective studies in which the exposure was measured before the onset of the disease, or on large cross-sectional studies. Notwithstanding the ample potential for bias in case-control studies based on prevalent cases, we included results from some of the larger case-control studies as well. The results from these studies should however be interpreted with caution. The associations between most putative determinants and PD still have to be confirmed in cohort studies, ideally in a community-based setting.

Age

Age is the most important risk factor for PD. Under the age of 45 years PD is very uncommon. Reported age-specific prevalence and incidence figures varied widely, which might be due to differences in case-finding procedures, diagnostic criteria, and response rates across studies. Case-finding methods that are based on existing medical records will miss patients who did not seek medical attention for their parkinsonism and will tend to underestimate prevalence and incidence.

Type
Chapter
Information
Investigating Neurological Disease
Epidemiology for Clinical Neurology
, pp. 174 - 195
Publisher: Cambridge University Press
Print publication year: 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×